Please login to the form below

Not currently logged in


This page shows the latest Imfinzi news and features for those working in and with pharma, biotech and healthcare.

AZ’s Imfinzi scores orphan drug status in liver cancer

AZ’s Imfinzi scores orphan drug status in liver cancer

AstraZeneca’s PD-L1 Imfinzi, and anti-CTLA4 antibody tremelimumab, have been granted orphan drug designations (ODD) in the US for liver cancer. ... Results from the  CASPIAN trial of Imfinzi in advanced small cell lung cancer revealed the drug

Latest news

More from news
Approximately 19 fully matching, plus 68 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 5 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Empowering Strategic Performance Ltd

OUR GOAL: To help clients Metamorph™ Science into Action that changes healthcare to improve the lives of patients. Empowering Strategic...

Latest intelligence

Happy Chinese New Year 2020 - The Year of The Rat
A fond farewell to The Year of the Pig...
White Paper for download - Explaining the price of your product
In this white paper, he breaks down the pricing options available to you, shares stories from his extensive experiences, and talks you through how to better define your pricing, step-by-step....
OPEN Health expands offering with the launch of a new Learning & Development specialist team
Enhanced expertise to deliver impactful internal training programmes for healthcare clients...